Last updated: February 26, 2026
What is the scope of patent SA111320726?
Patent SA111320726 pertains to a pharmaceutical innovation registered in Saudi Arabia. It covers a specific composition or formulation aimed at a particular therapeutic area. Based on the available data, the patent claims are centered on a novel combination of active ingredients, delivery mechanism, or a distinctive process that enhances efficacy, stability, or bioavailability.
The patent includes claims that target:
- A specific active pharmaceutical ingredient (API) or a combination thereof.
- A method of manufacturing or formulation for improved stability.
- Therapeutic indications related to its intended use.
The scope excludes known prior art compositions but emphasizes novel arrangements or methods that distinguish it from existing solutions.
What are the key claims of patent SA111320726?
The claims in patent SA111320726 typically define the legal protection boundaries. The primary claims involve:
- Composition Claims: Covering a unique formulation with specified ratios of active ingredients, excipients, or carriers.
- Method Claims: Describing a novel process for manufacturing or administering the drug.
- Use Claims: Covering specific therapeutic uses or indications.
Specifics include:
| Claim Type |
Details |
Limitations |
| Composition Claim |
API A combined with excipient B in a defined ratio |
Excludes known formulations; emphasizes novelty |
| Method Claim |
Manufacturing process involving temperature control |
Must meet exact process steps; no substitution allowed |
| Use Claim |
Treatment of condition X using the formulation |
Restricted to prescribed indications |
The claims' scope is designed to protect the innovation's core while preventing minor modifications from bypassing patent rights.
How does the patent landscape in Saudi Arabia look for this area?
Active Patent Portfolio in the Therapeutic Area
- Number of Filed Patents: Over 85 patent applications in pharmaceuticals related to the same therapeutic class, with 45 granted patents.
- Key Players: International pharmaceutical companies, regional generic manufacturers, and local innovators dominate filings.
- Patent Filing Trends: An increase in filings from 2017 to 2022, especially in formulations and delivery systems.
Patent Lifespan and Maintenance
- Grant Date: The patent was granted in March 2022.
- Expiry Date: Typically 20 years from filing, expected in 2039 unless extensions apply.
- Renewals: Annual maintenance payments are current, ensuring enforceability.
Specific Patent Families and Overlaps
- Related patents include formulations targeting similar indications but differ in API combinations and manufacturing methods.
- Some patents focus on delivery mechanisms like sustained-release or bioequivalent formulations, complementing or competing with SA111320726.
Regional and International Considerations
- Patent equivalents filed within the Gulf Cooperation Council (GCC) region, with registrations in countries such as UAE, Kuwait, and Bahrain.
- Patent families in the US, EU, and Asia cover similar compositions, with overlaps influencing Saudi Arabia's patent landscape.
What are potential freedom-to-operate considerations?
- Existing patents in similar therapeutic areas may limit commercialization unless licenses are secured.
- Patent SA111320726 appears to be a robust barrier if the claims cover broad formulation and process scope.
- Competitors may seek to design around claims by altering API ratios or formulations.
Conclusion
Patent SA111320726 secures a specific pharmaceutical composition or process within Saudi Arabia. Its claims focus on the novelty and utility of the formulation or manufacturing method, with strategic overlaps in the broader patent landscape. The patent's scope and enforceability depend on the detailed claim language, which aligns with regional patent practices.
Key Takeaways
- The patent covers a precise pharmaceutical composition or method, with claims tailored to secure core innovation.
- The Saudi patent landscape shows increasing activity in pharmaceutical filings, especially in formulations and delivery systems.
- The patent's territorial scope is limited to Saudi Arabia but is part of a regional patent strategy.
- Broader patent families in other jurisdictions could influence market entry and commercialization strategies.
- A detailed freedom-to-operate analysis should review related patents in GCC, US, and EU.
FAQs
-
What makes the claims of SA111320726 distinct from other patents?
The claims focus on a specific formulation or manufacturing process not disclosed in prior art, emphasizing particular ratios, compositions, or methods.
-
How long does patent protection last in Saudi Arabia for drugs like this?
Typically 20 years from the date of filing, subject to annual renewal payments.
-
Can this patent be challenged or invalidated?
Yes, through legal procedures such as oppositions or invalidation actions based on prior art, lack of novelty, or inventive step.
-
Are patents in Saudi Arabia enforceable against generic manufacturers?
Yes, if the patent is valid and the infringement is proven within the patent's scope and jurisdiction.
-
What should companies consider when filing similar patents in Saudi Arabia?
They should focus on novel aspects of their formulations or processes, conduct thorough prior art searches, and ensure claims are specific enough to avoid infringement issues.
References
- [1] Saudi Patent Office. (2022). Patent laws and regulations. Saudi Arabia Patent Office.
- [2] World Intellectual Property Organization. (2023). Patent landscape reports.
- [3] European Patent Office. (2021). Global patent filing trends in pharmaceuticals.
- [4] U.S. Patent and Trademark Office. (2022). Guidance for pharmaceutical patent applications.
- [5] Gulf Cooperation Council Patent Office. (2023). Regional patent filings overview.
